Next Article in Journal
Chronic Inhibition of Central Angiotensin-Converting Enzyme Ameliorates Colchicine-Induced Memory Impairment in Mice
Previous Article in Journal
Do the Characteristics of Xanthan Single Molecule Reflect the Behavior of Matrix Tablets?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 80
Issue 3
10.3797/scipharm.1205-09
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation

by
Satheeshmanikandan R. S. THAPPALI
1,*,
Kanthikiran VARANASI
1,
Sridhar VEERARAGHAVAN
1,
Rambabu ARLA
1,
Sandhya CHENNUPATI
1,
Madheswaran RAJAMANICKAM
1,
Swaroop VAKKALANKA
1 and
Mukkanti KHAGGA
2
1
Incozen Therapeutics Pvt. Ltd, Alexandria Knowledge Park, Shamirpet, Hyderabad, 500078, India
2
Centre for Pharmaceutical Sciences, JNT University, Kukatpally, Hyderabad, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2012, 80(3), 633-646; https://doi.org/10.3797/scipharm.1205-09
Submission received: 17 May 2012 / Accepted: 18 June 2012 / Published: 18 June 2012
Versions Notes

Abstract

A new method for the simultaneous determination of celecoxib, erlotinib, and its active metabolite desmethyl-erlotinib (OSI-420) in rat plasma, by liquid chromatography/tandem mass spectrometry with positive/negative ion-switching electrospray ionization mode, was developed and validated. Protein precipitation with methanol was selected as the method for preparing the samples. The analytes were separated on a reverse-phase C18 column (50mm×4.6mm i.d., 3μ) using methanol: 2 mM ammonium acetate buffer, and pH 4.0 as the mobile phase at a flow rate 0.8 mL/min. Sitagliptin and Efervirenz were used as the internal standards for quantification. The determination was carried out on a Theremo Finnigan Quantam ultra triple-quadrupole mass spectrometer, operated in selected reaction monitoring (SRM) mode using the following transitions monitored simultaneously: positive m/z 394.5→278.1 for erlotinib, m/z 380.3→278.1 for desmethyl erlotinib (OSI-420), and negative m/z −380.1→−316.3 for celecoxib. The limits of quantification (LOQs) were 1.5 ng/mL for Celecoxib, erlotinib, and OSI-420. Within- and between-day accuracy and precision of the validated method were within the acceptable limits of < 15% at all concentrations. The quantitation method was successfully applied for the simultaneous estimation of celecoxib, erlotinib, and desmethyl erlotinib in a pharmacokinetic study in Wistar rats.
Keywords: Celecoxib; Erlotinib; Desmethyl erlotinib; OSI-420; LC-MS/MS; Bioanalytical Celecoxib; Erlotinib; Desmethyl erlotinib; OSI-420; LC-MS/MS; Bioanalytical

Share and Cite

MDPI and ACS Style

THAPPALI, S.R.S.; VARANASI, K.; VEERARAGHAVAN, S.; ARLA, R.; CHENNUPATI, S.; RAJAMANICKAM, M.; VAKKALANKA, S.; KHAGGA, M. Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation. Sci. Pharm. 2012, 80, 633-646. https://doi.org/10.3797/scipharm.1205-09

AMA Style

THAPPALI SRS, VARANASI K, VEERARAGHAVAN S, ARLA R, CHENNUPATI S, RAJAMANICKAM M, VAKKALANKA S, KHAGGA M. Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation. Scientia Pharmaceutica. 2012; 80(3):633-646. https://doi.org/10.3797/scipharm.1205-09

Chicago/Turabian Style

THAPPALI, Satheeshmanikandan R. S., Kanthikiran VARANASI, Sridhar VEERARAGHAVAN, Rambabu ARLA, Sandhya CHENNUPATI, Madheswaran RAJAMANICKAM, Swaroop VAKKALANKA, and Mukkanti KHAGGA. 2012. "Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation" Scientia Pharmaceutica 80, no. 3: 633-646. https://doi.org/10.3797/scipharm.1205-09

APA Style

THAPPALI, S. R. S., VARANASI, K., VEERARAGHAVAN, S., ARLA, R., CHENNUPATI, S., RAJAMANICKAM, M., VAKKALANKA, S., & KHAGGA, M. (2012). Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation. Scientia Pharmaceutica, 80(3), 633-646. https://doi.org/10.3797/scipharm.1205-09

Article Metrics

Back to TopTop